bharat biotech

Oral Cholera Vaccine Launched After Successful Phase 3 Trial: Bharat Biotech

Bharat Biotech International Ltd announced on Tuesday the launch of Hillchol, an innovative single-strain oral cholera vaccine. According to a press release from the company, Hillchol (BBV131) was developed by Bharat Biotech under a license from Hilleman Laboratories, which is funded by Merck USA and the Wellcome Trust, to fight...

Bharat Biotech Initiates Clinical Trials For TB Vaccine ‘MTBVAC’ On Adults In India

Bharat Biotech International Ltd announced the commencement of clinical trials for the Tuberculosis vaccine MTBVAC on adults in India, marking a significant milestone in the fight against TB. Developed by the Spanish biopharmaceutical company Biofabri, MTBVAC represents the first vaccine against Tuberculosis derived from a human source. Conducted in close...

Bharat Biotech’s intranasal heterologous booster to hit market in Feb first week

According to reports, Bharat Biotech's intranasal heterologous booster dosage would be accessible on the market only in the first week of February. Bharat Biotech has introduced iNCOVACC (BBV154) as a booster dosage in the nation. Bharat Biotech gained permission from the Central Drugs Standard Control Organization (CDSCO) earlier this month...